Enhanced Anti-Tumoral Activity of Methotrexate-Human Serum Albumin Conjugated Nanoparticles
Author Information
Author(s): Taheri Azade, Dinarvand Rassoul, Atyabi Fatemeh, Ahadi Fatemeh, Nouri Farank Salman, Ghahremani Mohammad Hossein, Ostad Seyed Nasser, Borougeni Atefeh Taheri, Mansoori Pooria
Primary Institution: Tehran University of Medical Sciences
Hypothesis
Covalent attachment of LHRH molecules on the surface of MTX-HSA nanoparticles would improve the cytotoxic effect on LHRH receptor positive tumor cells.
Conclusion
The LHRH targeted MTX-HSA nanoparticles significantly increased the anti-tumoral activity of methotrexate compared to non-targeted nanoparticles.
Supporting Evidence
- LHRH targeted nanoparticles showed significantly higher cytotoxicity on LHRH receptor positive cells compared to non-targeted nanoparticles.
- The internalization of LHRH targeted nanoparticles was significantly greater in LHRH receptor positive cells.
- Stability tests indicated that the LHRH targeted MTX-HSA nanoparticles maintained their integrity over four weeks.
Takeaway
Scientists made special tiny balls that can deliver cancer medicine directly to cancer cells, making the medicine work better and hurt healthy cells less.
Methodology
The study involved preparing LHRH targeted MTX-HSA nanoparticles and testing their cytotoxicity on LHRH receptor positive and negative cell lines.
Limitations
The study primarily focused on in vitro results, which may not fully represent in vivo effectiveness.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website